Using Machine Learning to Identify Factors Affecting Antibody Production and Adverse Reactions After COVID-19

Nahomi Miyamoto1, Tohru Yamaguchi2, Yoshinori Tamada2

  • 1Research Institute of Health Innovation, Hirosaki University, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.

Vaccines
|February 26, 2026
PubMed